Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a potent and selective antagonist of the cannabinoid receptor type 1 (CB1R) and inducible nitric oxide synthase (iNOS), exhibiting a binding affinity (Ki) of 5.7 nM specifically for CB1R. Due to its characteristics, (Rac)-Zevaquenabant holds promise as an investigative tool in liver fibrosis research.
Description | (Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a potent and selective antagonist of the cannabinoid receptor type 1 (CB1R) and inducible nitric oxide synthase (iNOS), exhibiting a binding affinity (Ki) of 5.7 nM specifically for CB1R. Due to its characteristics, (Rac)-Zevaquenabant holds promise as an investigative tool in liver fibrosis research. |
Synonyms | (Rac)-MRI-1867, (Rac)-Zevaquenabant |
Molecular Weight | 547.98 |
Formula | C25H21ClF3N5O2S |
CAS No. | 1610420-28-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(Rac)-Zevaquenabant 1610420-28-4 (Rac)-MRI-1867 (Rac) Zevaquenabant MRI 1867 (Rac)Zevaquenabant MRI-1867 MRI1867 Zevaquenabant inhibitor inhibit